March 28, 2019
The company's share price soared over 45 percent after the release of positive results from a clinical trial.
May 25, 2017
Revive Therapeutics announced the results for the three and nine months ended March 31, 2017.
April 18, 2017
Prometic Life Sciences received approval from the US Food and Drug Administration for the PBI-4050 Phase 2/3 clinical trials.
April 13, 2017
Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...
March 8, 2017
Revive Therapeutics (TSX VENTURE:RVV) has announced Dr. Yanlin Wang will be joining the company as a scientific advisor for cannabinoid-based...
March 7, 2017
Nano Dimension (TASE:NNDM,NASDAQ:NNDM), a leader in the area of 3D printed electronics, today announced financial results for the fourth quarter...